• Publications
  • Influence
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
BACKGROUND Superficial basal-cell carcinoma is most commonly treated with topical non-surgical treatments, such as photodynamic therapy or topical creams. Photodynamic therapy is considered theExpand
  • 206
  • 9
Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta‐analysis of randomized and nonrandomized trials
Background  Several noninvasive treatment modalities are available for superficial basal cell carcinoma (sBCC).
  • 129
  • 6
Pain during topical photodynamic therapy: uncomfortable and unpredictable
Background  The major drawback of the widely used photodynamic therapy (PDT) is treatment‐related pain.
  • 57
  • 5
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
For the treatment of superficial basal cell carcinoma, a prospective, noninferiority, randomized controlled multicenter trial with 601 patients showed that 5% imiquimod cream was superior andExpand
  • 61
  • 2
Trends in the incidence of basal cell carcinoma by histopathological subtype
Background  As a result of the high prevalence, basal cell carcinoma (BCC) causes a significant and expensive health care problem.
  • 67
  • 2
Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
Clinical and histopathological differentiation between basal cell carcinoma (BCC) and trichoepithelioma (TE) is a frequent problem. Attempts have been made to identify immunohistochemical markersExpand
  • 19
  • 2
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study
Background: There have been concerns that recurrences after noninvasive therapy for basal cell carcinoma (BCC) transform into a “more aggressive” histologic subtype. Objective: We sought to evaluateExpand
  • 7
  • 2
Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer
The objective is to assess the ability of preoperative serum CA125 levels to identify patients at high risk of suboptimal cytoreductive surgery for epithelial ovarian cancer (EOC). One hundred andExpand
  • 36
  • 1
Randomized Trial of Four Treatment Approaches for Actinic Keratosis
Background Actinic keratosis is the most frequent premalignant skin disease in the white population. In current guidelines, no clear recommendations are made about which treatment is preferred.Expand
  • 46
  • 1
  • PDF
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and
BACKGROUND Noninvasive treatments are frequently used in treatment of superficial basal cell carcinoma (sBCC) because of better cosmetic results, lower costs, and less burden on health care servicesExpand
  • 21
  • 1